Evidence of a role for RANKL in the development of myeloma bone disease

Current Opinion in Pharmacology
Evy De LeenheerPeter I Croucher

Abstract

Multiple myeloma is associated with the development of a devastating bone disease mediated by increased osteoclastic activity. The ligand for receptor activator of nuclear factor-kappaB (RANKL) plays a critical role in normal osteoclast biology and is abnormally regulated in myeloma. Targeting this system with recombinant decoy receptor, osteoprotegerin, or soluble forms of the receptor activator of nuclear factor-kappaB is able to prevent myeloma bone disease in pre-clinical models. Intriguingly, inhibiting osteoclast formation and bone resorption, and altering the bone marrow microenvironment, results in an indirect anti-myeloma effect.

Citations

Feb 1, 2014·Breast Cancer Research and Treatment·Zanjing ZhaiKerong Dai
Dec 3, 2009·Clinical Lymphoma & Myeloma·Christian JakobOrhan Sezer
Oct 8, 2013·Expert Opinion on Therapeutic Patents·Seong Hwan Kim, Seong-Hee Moon
Jun 7, 2005·Expert Opinion on Therapeutic Targets·Klaus PodarKenneth C Anderson
Oct 27, 1998·Biological Psychiatry·D P DevanandH A Sackeim
Jul 22, 2014·Archives of Biochemistry and Biophysics·Marjolein van Driel, Johannes P T M van Leeuwen
Mar 17, 2009·The Oncologist·Franco SilvestrisFranco Dammacco

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis